Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Company Update

18 Oct 2023 13:37

RNS Number : 5640Q
Highbridge Tactical Credit Fund Ltd
18 October 2023
Β 

18 October 2023

Β 

Β 

HIGHBRIDGE TACTICAL CREDIT FUND LIMITED

("HTCF" or the "Company")

Β 

Β 

Β 

Company Update

Compulsory redemption

The Company's board (the Board) has resolved that pursuant to Article 138(2) of the Company's articles of incorporation, and subject to the provisions of The Companies (Guernsey ) Law, 2008 (the Company Law) , the Company will compulsorily redeem the majority of the Ordinary Shares in the Company on the 1 November 2023, leaving two shareholders, holding 1 share each, being the Chairman, Vic Holmes, and director, Steve Le Page, as the Company is required to have at least one member under the Company Law and in order that they may facilitate the placing of the Company into a voluntary liquidation immediately following the redemption.

Β 

The Board has made the decision to compulsorily redeem these Ordinary Shares to ensure that the current shareholders are treated no less favourably than redemption creditors (being former shareholders) by a liquidator. Under the Company Law, a liquidator is obliged to discharge the claims of creditors ahead of any monies due to shareholders.

Β 

Compulsory Redemption Date

1 November 2023Β 

Compulsory Redemption Record Date

31 October 2023

Aggregate amount to be distributed to shareholders

Initially nil with the potential for future distributions net ongoing expenses

Relevant Percentage of Ordinary Shares to be Redeemed

100% of shares less one share held by each director

Compulsory Redemption Price

Based on the NAV realised by the Liquidator from the underlying assets

New ISIN

n/a due to delisting of remaining shares on or around 1 November 2023

Β 

Shareholders should note that any amount they may ultimately receive in respect of this redemption will vary with the value of the underlying assets and the costs of the liquidation - as is the case for existing creditors of the Company arising from previous redemption events (see the most recent financial report of the Company for details). The Board cannot estimate the value of any of the elements in the underlying AllBlue portfolio due to the complexity of the structure. The apportionment policy for the proceeds of any fines successfully imposed by the FCA is also not known as these fines relate to several years of activity by BlueCrest.

Β 

The Company's shares will also be suspended from trading on the London Stock Exchange on 1 November 2023. Further, it is intended that immediately following the compulsory redemption, the Company's two shareholders will hold a short notice shareholder meeting to resolve to delist the Company's shares from the London Stock Exchange and appoint a liquidator. The Company also, as a cost saving measure, does not intend to publish its financial statements for the year ended 30 June 2023.

Β 

AllBlue

The Company's only remaining asset except for cash is the residual holding in AllBlue Limited.

Β 

Your Board understands the assets of AllBlue currently consist of:

Β 

1. An interest in the principal value of junior secured notes issued by Fernando JSN plc, with a sale unlikely to take place in the near future.

2. Settlement agreements which were reached in June 2023 in respect of legal claims (the "Claims") that were filed in New York and London in 2018 and 2019 respectively. Once the settlement amounts are received there will be no further recoveries associated with the Claims.

3. Residual investment portfolio positions which the Liquidators of AllBlue will continue to attempt realise for maximum value, but the potential for future significant recoveries is thought to be unlikely.

Β 

In addition, the FCA (in the form of a FCA Decision Notice) sought to impose a financial penalty of Β£40,806,700 on BlueCrest Capital Management (UK) LLP (BCMUK) as well as a redress program for non-US investors. According to a FCA Press Release, the FCA considers that between October 2011 and December 2015, BCMUK failed to manage fairly a conflict of interest relating to the allocation of time spent by portfolio managers on an internal fund. BCMUK elected to challenge the FCA Decision Notice and the redress requirement before the Upper Tribunal in the UK. The Upper Tribunal issued a decision on 21st June 2023 that the FCA's approach did not satisfy the necessary legal preconditions for imposing a redress scheme. Whilst the FCA Decision Notice did not disclose the amount of redress being considered for non-US investors an amount of USD 700 million is referenced in the Upper Tribunal decision. Both the FCA and BCMUK were granted permission to appeal the Upper Tribunal decision to an appellate court. Accordingly, the timeline and final outcome of the Upper Tribunal process remains uncertain.

Β 

A liquidator is obliged to discharge the claims of creditors ahead of any monies due to shareholders, and any future distributions from the Liquidators of AllBlue will be distributed accordingly.

Β 

Β 

Β 

For further information please contact:

Sanne Fund Services (Guernsey) Limited

Company Secretary

Β 

Tel: +44 (0) 20 3530 3111

Β 

LEI: 213800397SYHLYFH5961

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDFFIFEAEDSEDS
Date   Source Headline
29th Jul 20204:32 pmRNSNet Asset Value - Weekly Estimate
29th Jul 20202:17 pmRNS2019 Redemption Portfolio
29th Jul 20202:15 pmRNSNet Asset Value - Month End Final
21st Jul 20204:22 pmRNSNet Asset Value - Weekly Estimate
16th Jul 20202:44 pmRNSNet Asset Value - Weekly Estimate
8th Jul 20201:13 pmRNSNet Asset Value - Weekly Estimate
2nd Jul 20205:11 pmRNSProvision 4 of the UK Corporate Governance Code
2nd Jul 202010:03 amRNSNet Asset Value(s) - Weekly Estimate
26th Jun 20203:11 pmRNSHolding(s) in Company
24th Jun 20205:07 pmRNSNet Asset Value - Weekly Estimate
23rd Jun 20205:16 pmRNS2019 Redemption Portfolio
23rd Jun 20205:15 pmRNSNet Asset Value(s) - Month End Final
17th Jun 202012:46 pmRNSNet Asset Value(s) - Weekly Estimate
12th Jun 202011:27 amRNSNet Asset Value(s) - Weekly Estimate
4th Jun 20202:39 pmRNSNet Asset Value(s) - Weekly Estimate
28th May 20204:17 pmRNSNet Asset Value(s) - Month End Final
28th May 20204:08 pmRNS2019 Redemption Portfolio
28th May 20203:46 pmRNSNet Asset Value(s) - Weekly Estimate
21st May 20205:01 pmRNSNet Asset Value(s) - Weekly Estimate
15th May 20203:42 pmRNSNet Asset Value(s) - Weekly Estimate
6th May 20204:06 pmRNSNet Asset Value(s) - Weekly Estimate
5th May 20201:58 pmRNSDisclosure of rights attached to equity shares
5th May 20201:47 pmRNSDirector/PDMR Shareholding
4th May 20205:16 pmRNS2019 Redemption Portfolio
4th May 20204:41 pmRNSNet Asset Value(s) - Month End Final
1st May 202010:11 amRNSCorrection to Disclosure of Notifiable Interests
30th Apr 20203:39 pmRNSNet Asset Value(s) - Weekly Estimate
28th Apr 20206:31 pmRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSNotice of AGM
27th Apr 20207:00 amRNSAnnual Financial Report
23rd Apr 20204:53 pmRNSNet Asset Value(s) - Weekly Estimate
17th Apr 20203:39 pmRNSNet Asset Value(s) - Weekly Estimate
17th Apr 20209:15 amRNSNet Asset Value(s) - Weekly Estimate
14th Apr 20205:12 pmRNSCash Exit Payment
9th Apr 20205:39 pmRNSNet Asset Value(s) - Monthly Estimate
2nd Apr 20202:53 pmRNS2019 Redemption Portfolio
2nd Apr 20202:41 pmRNSNet Asset Value(s) - Weekly Estimate
26th Mar 20205:05 pmRNSNet Asset Value(s) - Month End Final
26th Mar 20204:53 pmRNSNet Asset Value(s) - Weekly Estimate
19th Mar 20201:31 pmRNSNet Asset Value(s)- Weekly Estimate
13th Mar 202011:41 amRNSHolding(s) in Company
12th Mar 20209:46 amRNSNet Asset Value(s) - Weekly Estimate
9th Mar 202012:20 pmRNSNet Asset Value(s) - Weekly Estimate
3rd Mar 20205:02 pmRNS2019 Redemption Portfolio
2nd Mar 20205:29 pmRNSNet Asset Value(s) - Month End Final
26th Feb 20203:33 pmRNSNet Asset Value(s) - Weekly Estimate
20th Feb 20202:05 pmRNSResult of EGM
19th Feb 20203:50 pmRNSNet Asset Value(s) - Weekly Estimate
12th Feb 20205:13 pmRNSNet Asset Value(s) - Weekly Estimate
7th Feb 20209:17 amRNS2019 Redemption Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.